Colorectal PolypAQUASNARENCT06040710
Artificial-intelligence-based QUAntification of Size measuremeNts of Adenoma in Routine Endoscopy
An observational study of Colorectal Polyp and Colorectal Adenoma, run by Wuerzburg University Hospital at 1 site in Germany.
Trial summary
Polyp size and count determines the follow-up intervals after colonoscopy. However, relying on the endoscopist's optical diagnosis for size estimation has shown considerable variability, leading to erroneous surveillance intervals and increased colorectal cancer risk. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Colorectal Polyp, Colorectal Adenoma
- What is being tested?
- POSEIDON size estimation software with the EndoMind polyp detection system
- Type of treatment
- Medical device
- How many people
- 145 participants
- Where
- 1 siteGermany
- Study dates
- 14 Feb 2024to 28 Mar 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Adult patients (>18 years), scheduled for screening, surveillance, or diagnostic colonoscopy
Who may be able to join
- Adult patients
- Scheduled for colonoscopy
Who cannot join
- Patient Level:
- Inflammatory Bowel Disease
- Familiar Polyposis Syndrome
- Data Level
- Failure to initialize system before examination
- Missing image instrument placed next to polyp to obtain gold standard
Trial locations and contacts
1 site in 1 country.
About this study
Polyp size and count determines the follow-up intervals after colonoscopy. However, relying on the endoscopist's optical diagnosis for size estimation has shown considerable variability, leading to erroneous surveillance intervals and increased colorectal cancer risk. This study aims to assess the effectiveness of a new polyp size estimation software, called POSEIDON, which uses the tip of the auxiliary water-jet as reference and is implemented together with the EndoMind polyp detection system.
Read the detailed description
Objective:
The primary aim of this study is to conduct a superiority analysis between POSEIDON and endoscopist optical estimation, focusing on the errors of polyp size measurement. Secondary objectives encompass subgroup analyses concerning varying polyp sizes and histology, potential impact on follow-up protocols based on polyp sizes, and determination of the percentage of cases where obtaining measurements with POSEIDON proves unfeasible.
Study Design:
Single center, endoscopist blinded study. Considering the results of the preliminary study, a total of 42 pairs of measurements suffices to extrapolate statistical significance for a power of 90% and a significance level of 0.05. Taking dropout rates, average number of polyps per patient, polyp detection rate, the number of patients expected to be enrolled for the study is 156. For obtaining the gold standard measurement, images from the examination recording where the tip of a snare is placed next to the polyp are extracted. The snare tip and polyp are manually segmented and their largest diameter in pixels is manually calculated. The diameter of the snare-tip will be measured after the examination to account for production based variations. Based on this, the gold standard polyp size is calculated.
AI setup and limitations:
The version of the polyp detection system, EndoMind, is an updated version of the one published in (PMID: 35543874). Notably, the POSEIDON method has undergone dual refinements from its first published version (PMID: 37080235). Firstly, the AI model for water-jet tip detection has been further trained using images from colonoscopy videos, leading to performance improvements. Secondly, the pixel-to-millimeter conversion methodology has been optimized to align with the specifications of the endoscopes employed in the trial.
To obtain a polyp size estimation, initially the polyp is detected by means of a bounding box through the EndoMind system. Then, once water-jet is sprayed next to the polyp, POSEIDON detects the tip of the water-jet, where it touches the mucosa. The coordinates of the tip in the endoscopic image are correlated to the distance of the endoscope to the mucosa. With the above, the largest diameter of the bounding box is converted from pixels to millimeters, resulting in the size estimation.
For measurement acquisition, the system is initiated at the beginning of the examination and deactivated at its conclusion, facilitated by a dedicated button press. Concerning expert-system interaction, the CADe system's identifications consistently appear on an auxiliary screen within the endoscopist's workspace. On this screen, precise visualization of the impact point between the water-jet beam and the mucosa follows water-jet detection. Subsequently, the endoscopist receives visual affirmation of a successful calculation of polyp size estimation, derived from the bounding box on the screen. The endoscopist evaluates the alignment of this box around the polyp to assess the accuracy measurement outcome. Importantly, throughout these operations, the endoscopist remains blinded to the size estimated by POSEIDON. The endoscopist also reports polyp cases where they are unable to obtain a proper measurement.
Study population:
All adult patients with screening or surveillance colonoscopies that do not match the exclusion criteria will be asked for informed consent.
Intervention:
Upon polyp identification by the endoscopist, the visual assessment will be conducted, followed by obtaining a satisfactory measurement using POSEIDON when possible, as described in the AI methods section. To eliminate potential learning bias and optimize efficiency, the examiner will be blinded to the immediate measurement result. Finally, after both measurements are obtained, an instrument tip of known size will be positioned adjacent to the polyp, which is to be later used for obtaining the gold-standard polyp size.
- Conditions
- Colorectal Polyp, Colorectal Adenoma
- Being tested
- POSEIDON size estimation software with the EndoMind polyp detection system
- Keywords
- Polyp Size, Colorectal Polyp, Artificial Intelligence, Endoscopy, Follow-up interval
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
POSEIDON size estimation software with the EndoMind polyp detection systemDevice
Polyp size estimation using the POSEIDON software and bounding boxes of the EndoMind polyp detection system.
| Study group | Role | What they receive |
|---|---|---|
| Experimental: Intervention arm | All patients within the study are included in the intervention arm: polyp detected within these patients will be measured according to the study protocol using two different methods. Receives: Device: POSEIDON size estimation software with the EndoMind polyp detection system |
What is being measured
The primary outcome is the main question the study is designed to answer.
Error of size estimation for colorectal polyps using POSEIDON versus physician optical evaluation
The error between gold standard polyp size and estimation using POSEIDON and optical estimation will be compared in pairs for the same polyps.
Measured: Through study completion, an average of 5 months
Secondary outcomes (4)
Error of size estimation for colorectal polyps using POSEIDON versus physician optical evaluation for different size categories
Polyps will be split into size categories based on national and international guidelines. The study will assess the errors of both POSEIDON and optical estimation within each group through pairwise comparison
Measured: Through study completion, an average of 5 months
Error of size estimation for colorectal polyps using POSEIDON versus physician optical evaluation for polyps with different histologies
Polyps will be split into based on their histological evaluation. The study will assess the errors of both POSEIDON and optical estimation within each group through pairwise comparison.
Measured: Through study completion, an average of 5 months
Rate of change in guideline-suggested follow-up interval based purely on detected polyp size.
The study determines follow-up intervals based on three international standards, solely considering polyp size estimated by the two methods.
Measured: Through study completion, an average of 5 months
Percentage of polyps where endoscopists failed to obtain POSEIDON measurement.
Evaluation of the percentage polyps for which the endoscopist was unable to obtain a proper measurement with the proposed method.
Measured: Through study completion, an average of 5 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Sep 2023
- Study start14 Feb 2024
- Primary completion28 Mar 2024
- Study completion28 Mar 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Colorectal PolypStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 145 participants (actual)
Sponsor and investigators
- Lead sponsor
- Wuerzburg University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06040710
- Sponsor's protocol ID
- AI02
- Acronym
- AQUASNARE
- Status last verified
- May 2025
- First submitted
- 8 Sep 2023
- Last updated
- 23 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Lux TJ, Banck M, Sassmannshausen Z, Troya J, Krenzer A, Fitting D, Sudarevic B, Zoller WG, Puppe F, Meining A, Hann A. Pilot study of a new freely available computer-aided polyp detection system in clinical practice. Int J Colorectal Dis. 2022 Jun;37(6):1349-1354. doi: 10.1007/s00384-022-04178-8. Epub 2022 May 11.
PubMed 35543874Sudarevic B, Sodmann P, Kafetzis I, Troya J, Lux TJ, Sassmannshausen Z, Herlod K, Schmidt SA, Brand M, Schottker K, Zoller WG, Meining A, Hann A. Artificial intelligence-based polyp size measurement in gastrointestinal endoscopy using the auxiliary waterjet as a reference. Endoscopy. 2023 Sep;55(9):871-876. doi: 10.1055/a-2077-7398. Epub 2023 Apr 20.
PubMed 37080235
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Artificial-intelligence-based QUAntification of Size measuremeNts of Adenoma in Routine Endoscopy
- ClinicalTrials.gov ID
- NCT06040710
- Acronym / sponsor ID
- AQUASNARE / AI02
- Conditions
- Colorectal Polyp, Colorectal Adenoma
- Keywords
- Polyp Size, Colorectal Polyp, Artificial Intelligence, Endoscopy, Follow-up interval
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 145 participants (actual)
- Lead sponsor
- Wuerzburg University HospitalUniversity, hospital or other
- Study start
- 14 Feb 2024 (actual)
- Primary completion
- 28 Mar 2024 (actual)
- Study completion
- 28 Mar 2024 (actual)
- First posted
- 15 Sep 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Polyp size and count determines the follow-up intervals after colonoscopy. However, relying on the endoscopist's optical diagnosis for size estimation has shown considerable variability, leading to erroneous surveillance intervals and increased colorectal cancer risk. This study aims to assess the effectiveness of a new polyp size estimation software, called POSEIDON, which uses the tip of the auxiliary water-jet as reference and is implemented together with the EndoMind polyp detection system.
Detailed description
Objective:
The primary aim of this study is to conduct a superiority analysis between POSEIDON and endoscopist optical estimation, focusing on the errors of polyp size measurement. Secondary objectives encompass subgroup analyses concerning varying polyp sizes and histology, potential impact on follow-up protocols based on polyp sizes, and determination of the percentage of cases where obtaining measurements with POSEIDON proves unfeasible.
Study Design:
Single center, endoscopist blinded study. Considering the results of the preliminary study, a total of 42 pairs of measurements suffices to extrapolate statistical significance for a power of 90% and a significance level of 0.05. Taking dropout rates, average number of polyps per patient, polyp detection rate, the number of patients expected to be enrolled for the study is 156. For obtaining the gold standard measurement, images from the examination recording where the tip of a snare is placed next to the polyp are extracted. The snare tip and polyp are manually segmented and their largest diameter in pixels is manually calculated. The diameter of the snare-tip will be measured after the examination to account for production based variations. Based on this, the gold standard polyp size is calculated.
AI setup and limitations:
The version of the polyp detection system, EndoMind, is an updated version of the one published in (PMID: 35543874). Notably, the POSEIDON method has undergone dual refinements from its first published version (PMID: 37080235). Firstly, the AI model for water-jet tip detection has been further trained using images from colonoscopy videos, leading to performance improvements. Secondly, the pixel-to-millimeter conversion methodology has been optimized to align with the specifications of the endoscopes employed in the trial.
To obtain a polyp size estimation, initially the polyp is detected by means of a bounding box through the EndoMind system. Then, once water-jet is sprayed next to the polyp, POSEIDON detects the tip of the water-jet, where it touches the mucosa. The coordinates of the tip in the endoscopic image are correlated to the distance of the endoscope to the mucosa. With the above, the largest diameter of the bounding box is converted from pixels to millimeters, resulting in the size estimation.
For measurement acquisition, the system is initiated at the beginning of the examination and deactivated at its conclusion, facilitated by a dedicated button press. Concerning expert-system interaction, the CADe system's identifications consistently appear on an auxiliary screen within the endoscopist's workspace. On this screen, precise visualization of the impact point between the water-jet beam and the mucosa follows water-jet detection. Subsequently, the endoscopist receives visual affirmation of a successful calculation of polyp size estimation, derived from the bounding box on the screen. The endoscopist evaluates the alignment of this box around the polyp to assess the accuracy measurement outcome. Importantly, throughout these operations, the endoscopist remains blinded to the size estimated by POSEIDON. The endoscopist also reports polyp cases where they are unable to obtain a proper measurement.
Study population:
All adult patients with screening or surveillance colonoscopies that do not match the exclusion criteria will be asked for informed consent.
Intervention:
Upon polyp identification by the endoscopist, the visual assessment will be conducted, followed by obtaining a satisfactory measurement using POSEIDON when possible, as described in the AI methods section. To eliminate potential learning bias and optimize efficiency, the examiner will be blinded to the immediate measurement result. Finally, after both measurements are obtained, an instrument tip of known size will be positioned adjacent to the polyp, which is to be later used for obtaining the gold-standard polyp size.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Experimental: Intervention arm | – | Device: POSEIDON size estimation software with the EndoMind polyp detection systemAll patients within the study are included in the intervention arm: polyp detected within these patients will be measured according to the study protocol using two different methods. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients (>18 years), scheduled for screening, surveillance, or diagnostic colonoscopy
Key inclusion criteria (2 listed)
- Adult patients
- Scheduled for colonoscopy
Key exclusion criteria (6 listed)
- Inflammatory Bowel Disease
- Familiar Polyposis Syndrome
- Data Level
- Failure to initialize system before examination
- Missing image instrument placed next to polyp to obtain gold standard
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| POSEIDON size estimation software with the EndoMind polyp detection systemPolyp size estimation using the POSEIDON software and bounding boxes of the EndoMind polyp detection system. | Device | Experimental: Intervention arm |
Primary outcome
Error of size estimation for colorectal polyps using POSEIDON versus physician optical evaluation
Time frame: Through study completion, an average of 5 months
The error between gold standard polyp size and estimation using POSEIDON and optical estimation will be compared in pairs for the same polyps.
4 secondary outcomes
Error of size estimation for colorectal polyps using POSEIDON versus physician optical evaluation for different size categories
Time frame: Through study completion, an average of 5 months
Error of size estimation for colorectal polyps using POSEIDON versus physician optical evaluation for polyps with different histologies
Time frame: Through study completion, an average of 5 months
Rate of change in guideline-suggested follow-up interval based purely on detected polyp size.
Time frame: Through study completion, an average of 5 months
Percentage of polyps where endoscopists failed to obtain POSEIDON measurement.
Time frame: Through study completion, an average of 5 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2025.
- Background: PubMed 35543874Lux TJ, Banck M, Sassmannshausen Z, Troya J, Krenzer A, Fitting D, Sudarevic B, Zoller WG, Puppe F, Meining A, Hann A. Pilot study of a new freely available computer-aided polyp detection system in clinical practice. Int J Colorectal Dis. 2022 Jun;37(6):1349-1354. doi: 10.1007/s00384-022-04178-8. Epub 2022 May 11.
- Background: PubMed 37080235Sudarevic B, Sodmann P, Kafetzis I, Troya J, Lux TJ, Sassmannshausen Z, Herlod K, Schmidt SA, Brand M, Schottker K, Zoller WG, Meining A, Hann A. Artificial intelligence-based polyp size measurement in gastrointestinal endoscopy using the auxiliary waterjet as a reference. Endoscopy. 2023 Sep;55(9):871-876. doi: 10.1055/a-2077-7398. Epub 2023 Apr 20.
- Individual participant dataSharing planned: No
Related trials for Colorectal Polyp
Recruiting
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
Recruiting
Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology
Colonic Neoplasms
RecruitingObservational study
KLF4 Epigenetic Modulation
KLF4 Methylation, Epigenetic
RecruitingObservational study
Malignant Polyp Registry
Malignant Colorectal Polyp, Colorectal Cancer
Not yet recruiting
Social Software-Based Intelligent Management System for Bowel Preparation
Colorectal Polyp, Colorectal Adenoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Colorectal Polyp and Colorectal Adenoma, run by Wuerzburg University Hospital at 1 site in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Error of size estimation for colorectal polyps using POSEIDON versus physician optical evaluation (time frame: Through study completion, an average of 5 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06040710, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2025.